Delivery Order SPE2DB24D3013-SPE2DB25FFJAF
Award Date
1/22/25
Potential Completion Date
2/12/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BOTOX 100 unit vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $8,613.60. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 19, 2025. The contract is not designated as a set-aside award. Amerisourcebergen...
This federal contract award is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract, a Delivery Order valued at $5,239.17, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a firm fixed-price pricing type and an ultimate completion date of November 29, 2024. This contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 8, 2025, with a ceiling value of $8,547.90 and a completion date of January 30, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating open...
This federal contract award is for the delivery of BOTOX 200 unit vials to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $23,285.20. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,296.60 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 13, 2025. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the provision of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a Delivery Order valued at $5,821.30. The award has an ultimate completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the delivery of BOTOX 100 unit vials to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,437.28 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and is a delivery order with an ultimate completion date of December 24, 2024. There is no set-aside designation for this contract. Amerisourcebergen...
This federal contract award is for the delivery of 200 unit vials of BOTOX pharmaceutical to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $14,553.25 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 15, 2024 and was awarded on October 24, 2024. This delivery order is part of a larger...
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. The $5,821.30 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, and does not have a set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This federal contract award is for the delivery of 200-unit vials of Botox to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $11,642.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of August 5, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp...